Delivery Order SPE2DB24D3013-SPE2DB25FFPWS
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for RINVOQ ER 15 mg tablets (30-count units) valued at $14,927.84. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The order is scheduled for completion by August 26, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. RINVOQ is an oral Janus kinase inhibitor...
- The Defense Logistics Agency awarded a delivery order valued at $7,154.87 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for RINVOQ ER 15 MG tablets in a quantity of 30 units, with a ceiling value of $26,170.68. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is expected to be completed by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,724.63 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $17,437.44. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, represents a non-set-aside competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $5,399.73. This is a firm fixed price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,396.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for RINVOQ ER 45 mg tablets in a quantity of 28 units. This is a firm fixed-price delivery order with a ceiling value of $16,702.20 and an ultimate completion date of August 11, 2025. The contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $48,868.27 for RINVOQ ER 30 mg tablets (30-count units) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat inflammatory conditions, and this...
- The Defense Logistics Agency awarded a delivery order valued at $7,177.04 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on April 22, 2025, with an ultimate completion date of April 23, 2025. This non-competitive delivery order utilizes firm fixed price terms and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions,...